Emma Frith
Impact in
-
- Cancer survivorship and care
- Bone health and treatments
-
- Platelet Disorders and Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
- Oncology 7
- Cancer survivorship and care 3
- Bone health and treatments 2
- CAR-T cell therapy research 1
-
- TGF-β signaling in diseases 3
- Bone Metabolism and Diseases 2
- Angiogenesis and VEGF in Cancer 1
- Co-authors
- Juliet Compston (3 shared papers)S Bord (3 shared papers)D.C. Ireland (2 shared papers)Mike Scott (2 shared papers)John M. Craig (1 shared paper)Eila Watson (4 shared papers)Peter W. Rose (4 shared papers)Jane Wolstenholme (4 shared papers)
- Journals
- Bone (1 paper)Tissue Engineering Part C Methods (1 paper)Cytotherapy (1 paper)BMJ Open (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- United KingdomPortugal
In The Last Decade
Emma Frith
9 papers receiving 313 citations
Peers
Comparison fields: 5 of 59
- Oncology 137
- Hematology 42
- Genetics 36
- Orthopedics and Sports Medicine 18
- Immunology and Allergy 8
Countries citing papers authored by Emma Frith
This map shows the geographic impact of Emma Frith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Frith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Frith more than expected).
Fields of papers citing papers by Emma Frith
This network shows the impact of papers produced by Emma Frith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Frith. The network helps show where Emma Frith may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma Frith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 121 | |
| 2 | 2005 | 54 | |
| 3 | 2004 | 49 | |
| 4 | 2004 | 28 | |
| 5 | 2008 | 27 | |
| 6 | 2017 | 19 | |
| 7 | 2014 | 10 | |
| 8 | 2015 | 6 | |
| 9 | 2017 | 4 |
About Emma Frith
Emma Frith is a scholar working on Oncology, Molecular Biology, Endocrinology, Diabetes and Metabolism, Genetics and Economics and Econometrics, having authored 9 papers that have together received 318 indexed citations. Recurring topics across this work include TGF-β signaling in diseases (3 papers), Cancer survivorship and care (3 papers), Bone Metabolism and Diseases (2 papers), Bone health and treatments (2 papers), Growth Hormone and Insulin-like Growth Factors (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Estrogen and related hormone effects (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (137 citations), Hematology (42 citations), Genetics (36 citations), Orthopedics and Sports Medicine (18 citations) and Immunology and Allergy (8 citations). Emma Frith has collaborated with scholars based in United Kingdom and Portugal. Frequent co-authors include Juliet Compston, S Bord, D.C. Ireland, Mike Scott, John M. Craig, Eila Watson, Peter W. Rose, Jane Wolstenholme, Marion L. Scott and Christine Campbell. Their work appears in journals such as Bone, Tissue Engineering Part C Methods, Cytotherapy, BMJ Open and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.